MolPharm Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 


Receive this page by email each issue: [Sign up for eTOCs]

Cover Caption
Other Issues:
March 2000; 57 (3)   [Index by Author]  [Cover Caption]
       Accelerated Communications
       Articles
Find articles in this issue containing these words:
[Search ALL Issues]


To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Accelerated Communications:

Alexey G. Mukhin, Daniela Gündisch, Andrew G. Horti, Andrei O. Koren, Gilles Tamagnan, Alane S. Kimes, Joann Chambers, D. Bruce Vaupel, Sarah L. King, Marina R. Picciotto, Robert B. Innis, and Edythe D. London
5-Iodo-A-85380, an alpha 4beta 2 Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors
Mol Pharmacol 2000 57: 642-649. [Abstract] [Full Text] [PDF]  

Articles:

Thierry Galvez, Stephan Urwyler, Laurent Prézeau, Johannes Mosbacher, Cécile Joly, Barbara Malitschek, Jakob Heid, Isabelle Brabet, Wolfgang Froestl, Bernhard Bettler, Klemens Kaupmann, and Jean-Philippe Pin
Ca2+ Requirement for High-Affinity gamma -Aminobutyric Acid (GABA) Binding at GABAB Receptors: Involvement of Serine 269 of the GABABR1 Subunit
Mol Pharmacol 2000 57: 419-426. [Abstract] [Full Text] [PDF]  

Huige Li and Ulrich Förstermann
Structure-Activity Relationship of Staurosporine Analogs in Regulating Expression of Endothelial Nitric-Oxide Synthase Gene
Mol Pharmacol 2000 57: 427-435. [Abstract] [Full Text] [PDF]  

Ray A. Leppik, Anita Mynett, Sebastian Lazareno, and Nigel J. M. Birdsall
Allosteric Interactions between the Antagonist Prazosin and Amiloride Analogs at the Human alpha 1A-Adrenergic Receptor
Mol Pharmacol 2000 57: 436-445. [Abstract] [Full Text] [PDF]  

M. Li, J. C. Bermak, Z. W. Wang, and Q. Y. Zhou
Modulation of Dopamine D2 Receptor Signaling by Actin-Binding Protein (ABP-280)
Mol Pharmacol 2000 57: 446-452. [Abstract] [Full Text] [PDF]  

Ming-Biao Yin, Bin Guo, Udo Vanhoefer, Rami G. Azrak, Hans Minderman, Cheryl Frank, Carol Wrzosek, Harry K. Slocum, and Youcef M. Rustum
Characterization of Protein Kinase chk1 Essential for the Cell Cycle Checkpoint after Exposure of Human Head and Neck Carcinoma A253 Cells to a Novel Topoisomerase I Inhibitor BNP1350
Mol Pharmacol 2000 57: 453-459. [Abstract] [Full Text] [PDF]  

Sharon L. Grant, Bernard Lassègue, Kathy K. Griendling, Masuko Ushio-Fukai, P. Reid Lyons, and R. Wayne Alexander
Specific Regulation of RGS2 Messenger RNA by Angiotensin II in Cultured Vascular Smooth Muscle Cells
Mol Pharmacol 2000 57: 460-467. [Abstract] [Full Text] [PDF]  

Neville J. Butcher, Kenneth F. Ilett, and Rodney F. Minchin
Substrate-Dependent Regulation of Human Arylamine N-Acetyltransferase-1 in Cultured Cells
Mol Pharmacol 2000 57: 468-473. [Abstract] [Full Text] [PDF]  

Berit X. Carlson, A. Christine Engblom, Uffe Kristiansen, Arne Schousboe, and Richard W. Olsen
A Single Glycine Residue at the Entrance to the First Membrane-Spanning Domain of the gamma -Aminobutyric Acid Type A Receptor beta 2 Subunit Affects Allosteric Sensitivity to GABA and Anesthetics
Mol Pharmacol 2000 57: 474-484. [Abstract] [Full Text] [PDF]  

Christopher M. Coulis, Chunja Lee, Violet Nardone, and Rebecca D. Prokipcak
Inhibition of c-myc Expression in Cells by Targeting an RNA-Protein Interaction Using Antisense Oligonucleotides
Mol Pharmacol 2000 57: 485-494. [Abstract] [Full Text] [PDF]  

Lionel Mouledous, Christopher M. Topham, Christiane Moisand, Catherine Mollereau, and Jean-Claude Meunier
Functional Inactivation of the Nociceptin Receptor by Alanine Substitution of Glutamine 286 at the C Terminus of Transmembrane Segment VI: Evidence from a Site-Directed Mutagenesis Study of the ORL1 Receptor Transmembrane-Binding Domain
Mol Pharmacol 2000 57: 495-502. [Abstract] [Full Text] [PDF]  

Katharine E. Pestell, Stephen M. Hobbs, Jenny C. Titley, Lloyd R. Kelland, and Michael I. Walton
Effect of p53 Status on Sensitivity to Platinum Complexes in a Human Ovarian Cancer Cell Line
Mol Pharmacol 2000 57: 503-511. [Abstract] [Full Text] [PDF]  

David W. Pyatt, Yanzhu Yang, Brenda Mehos, Anh Le, Wayne Stillman, and Richard D. Irons
Hematotoxicity of the Chinese Herbal Medicine Tripterygium wilfordii Hook f in CD34-Positive Human Bone Marrow Cells
Mol Pharmacol 2000 57: 512-518. [Abstract] [Full Text] [PDF]  

Michael D. Hlubek, Edward L. Stuenkel, Valery G. Krasnoperov, Alexander G. Petrenko, and Ronald W. Holz
Calcium-Independent Receptor for alpha -Latrotoxin and Neurexin 1alpha Facilitate Toxin-Induced Channel Formation: Evidence That Channel Formation Results from Tethering of Toxin to Membrane
Mol Pharmacol 2000 57: 519-528. [Abstract] [Full Text] [PDF]  

I. Imawati Budihardjo, Scott A. Boerner, Steven Eckdahl, Phyllis A. Svingen, Robert Rios, Matthew M. Ames, and Scott H. Kaufmann
Effect of 6-Aminonicotinamide and Other Protein Synthesis Inhibitors on Formation of Platinum-DNA Adducts and Cisplatin Sensitivity
Mol Pharmacol 2000 57: 529-538. [Abstract] [Full Text] [PDF]  

Timothy M. Palmer and Gary L. Stiles
Identification of Threonine Residues Controlling the Agonist-Dependent Phosphorylation and Desensitization of the Rat A3 Adenosine Receptor
Mol Pharmacol 2000 57: 539-545. [Abstract] [Full Text] [PDF]  

Gail Ferguson, Kenneth R. Watterson, and Timothy M. Palmer
Subtype-Specific Kinetics of Inhibitory Adenosine Receptor Internalization Are Determined by Sensitivity to Phosphorylation by G Protein-Coupled Receptor Kinases
Mol Pharmacol 2000 57: 546-552. [Abstract] [Full Text] [PDF]  

Cécile Combeau, Jean Provost, Frédérique Lancelin, Yann Tournoux, François Prod'homme, Frédéric Herman, François Lavelle, Jean Leboul, and Marc Vuilhorgne
RPR112378 and RPR115781: Two Representatives of a New Family of Microtubule Assembly Inhibitors
Mol Pharmacol 2000 57: 553-563. [Abstract] [Full Text] [PDF]  

Ludwig Missiaen, Humbert DeSmedt, Geert Bultynck, Sara Vanlingen, Patrick Desmet, Geert Callewaert, and Jan B. Parys
Calmodulin Increases the Sensitivity of Type 3 Inositol-1,4,5-trisphosphate Receptors to Ca2+ Inhibition in Human Bronchial Mucosal Cells
Mol Pharmacol 2000 57: 564-567. [Abstract] [Full Text] [PDF]  

Pascal Verdier-Pinard, Zhiqiang Wang, Arasambattu K. Mohanakrishnan, Mark Cushman, and Ernest Hamel
A Steroid Derivative with Paclitaxel-Like Effects on Tubulin Polymerization
Mol Pharmacol 2000 57: 568-575. [Abstract] [Full Text] [PDF]  

Todd L. Anthony, Heddwen L. Brooks, Daniela Boassa, Sergey Leonov, Gina M. Yanochko, John W. Regan, and Andrea J. Yool
Cloned Human Aquaporin-1 Is a Cyclic GMP-Gated Ion Channel
Mol Pharmacol 2000 57: 576-588. [Abstract] [Full Text] [PDF]  

Alexander Storch, Heike Blessing, Markus Bareiss, Sinje Jankowski, Zao Dung Ling, Paul Carvey, and Johannes Schwarz
Catechol-O-methyltransferase Inhibition Attenuates Levodopa Toxicity in Mesencephalic Dopamine Neurons
Mol Pharmacol 2000 57: 589-594. [Abstract] [Full Text] [PDF]  

Christine T. Murphy, Andrew M. Riley, Steve J. Mills, Catherine J. Lindley, Barry V. L. Potter, and John Westwick
myo-Inositol 1,4,6-Trisphosphorothioate and myo-Inositol 1,3,6-Trisphosphorothioate: Partial Agonists with Very Low Intrinsic Activity at the Platelet myo-Inositol 1,4,5-Trisphosphate Receptor
Mol Pharmacol 2000 57: 595-601. [Abstract] [Full Text] [PDF]  

Mette M. Rosenkilde and Thue W. Schwartz
Potency of Ligands Correlates with Affinity Measured against Agonist and Inverse Agonists but Not against Neutral Ligand in Constitutively Active Chemokine Receptor
Mol Pharmacol 2000 57: 602-609. [Abstract] [Full Text] [PDF]  

Stephan Immenschuh, Vera Hinke, Norbert Katz, and Thomas Kietzmann
Transcriptional Induction of Heme Oxygenase-1 Gene Expression by Okadaic Acid in Primary Rat Hepatocyte Cultures
Mol Pharmacol 2000 57: 610-618. [Abstract] [Full Text] [PDF]  

Ann-Sofie Johansson, Marianne Ridderström, and Bengt Mannervik
The Human Glutathione Transferase P1-1 Specific Inhibitor TER 117 Designed for Overcoming Cytostatic-Drug Resistance Is also a Strong Inhibitor of Glyoxalase I
Mol Pharmacol 2000 57: 619-624. [Abstract] [Full Text] [PDF]  

Stéphanie Chauvin, Annette Bérault, Yannick Lerrant, Marcel Hibert, and Raymond Counis
Functional Importance of Transmembrane Helix 6 Trp279 and Exoloop 3 Val299 of Rat Gonadotropin-Releasing Hormone Receptor
Mol Pharmacol 2000 57: 625-633. [Abstract] [Full Text] [PDF]  

Jerzy Madon, Bruno Hagenbuch, Lukas Landmann, Peter J. Meier, and Bruno Stieger
Transport Function and Hepatocellular Localization of mrp6 in Rat Liver
Mol Pharmacol 2000 57: 634-641. [Abstract] [Full Text] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.


Cover Caption:

About the cover: Model for the activation of oxytocin receptors. The left panel shows a minimized structure of a constitutively active mutant of the human oxytocin receptor. The right panel shows a model of the interaction between oxytocin and the wild-type receptor, and for comparison the center panel shows a complex between oxytocin and inactive mutant of the receptor. Receptors are depicted as helix ribbon bundles in cross-section through the surface membrane, with the intracellular surface at the top and the extracellular surface at the bottom. The solvent-accessible surfaces are represented by dot-clouds and predict that the activation process involves the opening of a solvent-exposed cytosolic crevice. From Fanelli F, Barbier P, Zanchetta D, de Benedetti PG and Chini B (1999) Activation mechanism of human oxytocin receptor: A combined study of experimental and computer-simulated mutagenesis. Mol Pharmacol 56:214-225.



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
The Journal of Pharmacology and Experimental 
Therapeutics Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics